[go: up one dir, main page]

ATE474049T1 - Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren - Google Patents

Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren

Info

Publication number
ATE474049T1
ATE474049T1 AT06017055T AT06017055T ATE474049T1 AT E474049 T1 ATE474049 T1 AT E474049T1 AT 06017055 T AT06017055 T AT 06017055T AT 06017055 T AT06017055 T AT 06017055T AT E474049 T1 ATE474049 T1 AT E474049T1
Authority
AT
Austria
Prior art keywords
monocytes
methods
nucleic acids
related compositions
compositions
Prior art date
Application number
AT06017055T
Other languages
English (en)
Inventor
Elizabeth Bates
Nathalie Fournier
Lionel Chalus
Pierre Garrone
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE474049T1 publication Critical patent/ATE474049T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT06017055T 1998-12-31 1999-12-29 Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren ATE474049T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22391998A 1998-12-31 1998-12-31
US22460498A 1998-12-31 1998-12-31

Publications (1)

Publication Number Publication Date
ATE474049T1 true ATE474049T1 (de) 2010-07-15

Family

ID=26918252

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06017055T ATE474049T1 (de) 1998-12-31 1999-12-29 Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren

Country Status (10)

Country Link
US (6) US6774214B1 (de)
EP (2) EP1770160A1 (de)
JP (2) JP4629873B2 (de)
CN (1) CN1352685A (de)
AR (1) AR022150A1 (de)
AT (1) ATE474049T1 (de)
AU (1) AU2710400A (de)
CA (1) CA2358562A1 (de)
DE (1) DE69942594D1 (de)
WO (1) WO2000040721A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105303A1 (en) * 1996-12-06 2003-06-05 Schering Corporation, A New Jersey Corporation Isolated mammalian monocyte cell genes; related reagents
ATE474049T1 (de) * 1998-12-31 2010-07-15 Schering Corp Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren
KR100941678B1 (ko) * 2007-12-17 2010-02-12 강원대학교산학협력단 암세포의 전이 억제 활성을 갖는 폴리펩타이드 또는 그의융합 단백질
CA2708648A1 (en) 2007-12-20 2009-07-09 Schering Corporation Fdf03 antibodies and uses thereof
KR101061016B1 (ko) 2008-09-17 2011-08-31 강원대학교산학협력단 암세포의 성장 억제 및 염증 질환의 예방 또는 치료활성을 갖는 폴리펩타이드 또는 그의 융합 단백질
US20120128673A1 (en) 2009-05-20 2012-05-24 Schering Corporation Modulation of pilr receptors to treat microbial infections
WO2011084357A1 (en) 2009-12-17 2011-07-14 Schering Corporation Modulation of pilr to treat immune disorders
ES2666550T3 (es) 2011-04-19 2018-05-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anticuerpos monoclonales humanos específicos para glipicano 3 y uso de los mismos
KR101927912B1 (ko) * 2016-11-01 2018-12-11 현대자동차주식회사 단말기, 단말기와 통신하는 차량, 단말기와 통신하는 퍼스널 모빌리티, 단말기의 제어 방법 및 차량의 제어 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470925A (en) * 1982-05-05 1984-09-11 E. I. Du Pont De Nemours And Company Immunoglobulin half-molecules and process for producing hybrid antibodies
DK580789D0 (da) * 1989-11-20 1989-11-20 Novo Nordisk As Fremgangsmaade til oprensning af polypeptider
EP2161338A1 (de) * 1996-12-06 2010-03-10 Schering Corporation Isolierte Säugetier-Monozytzellgene, zugehörige Reagenzien
AU5796298A (en) * 1996-12-11 1998-07-03 Chiron Corporation Secreted human proteins
AU6590898A (en) * 1997-03-28 1998-10-22 Genetics Institute Inc. Secreted proteins and polynucleotides encoding them
EP1029034A4 (de) * 1997-10-06 2003-04-09 Millennium Pharm Inc Signalpeptid enthaltende proteine und deren verwendung
JP2002519030A (ja) * 1998-06-26 2002-07-02 インサイト・ファーマスーティカルズ・インコーポレイテッド ヒトシグナルペプチド含有タンパク質
ATE474049T1 (de) 1998-12-31 2010-07-15 Schering Corp Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren

Also Published As

Publication number Publication date
JP4629873B2 (ja) 2011-02-09
WO2000040721A1 (en) 2000-07-13
US20150004608A1 (en) 2015-01-01
AU2710400A (en) 2000-07-24
JP4969638B2 (ja) 2012-07-04
CA2358562A1 (en) 2000-07-13
US20120009579A1 (en) 2012-01-12
US7932357B2 (en) 2011-04-26
US6774214B1 (en) 2004-08-10
US8426144B2 (en) 2013-04-23
CN1352685A (zh) 2002-06-05
EP1770160A1 (de) 2007-04-04
EP1141292A1 (de) 2001-10-10
DE69942594D1 (de) 2010-08-26
JP2002534087A (ja) 2002-10-15
US20100267022A1 (en) 2010-10-21
AR022150A1 (es) 2002-09-04
US20040137506A1 (en) 2004-07-15
US20130230855A1 (en) 2013-09-05
US8026351B2 (en) 2011-09-27
JP2010068810A (ja) 2010-04-02

Similar Documents

Publication Publication Date Title
ATE351910T1 (de) Ob-fusionsprotein enthaltende zusammensetzungen und verfahren
DE60003250D1 (de) Reinigungszusammensetzungen und Verfahren zur Reinigung
ATE288278T1 (de) Verfahren und zusammensetzungen zur peptidsynthese
EP1088333A4 (de) Verfahren und zussamensetzungen zur verbindung von osteoprose
ATE277621T1 (de) Verfahren und zusammensetzungen zur prävention von toleranz von bronchodilatoren
DE60140895D1 (de) Zusammensetzung und verfahren
EP1006796A4 (de) Zusammensetzungen und verfahren zur applikation von borrelia dna
EP0981511A4 (de) Methoden und zusammensetzungen zur selektiven modifikation von nukleinsäuren
DE60129522D1 (de) Gipszusammensetzungen und dazugehörende verfahren
DE69835022D1 (de) Proteinzusammensetzung und verfahren zur isolierung einer proteinzusammensetzung aus muskeln
DE69930964D1 (de) Zusammensetzungen und verfahren für mukosale abgabe
ATE510555T1 (de) Chemisch modifizierte neue erythropoietin- stimulierende protein zusammensetzungen und verfahren
DE69829562D1 (de) Hydrocyanierungsverfahren und darin verwendbare mehrzähnigen phosphit liganden und katalysatorzusammensetzungen aus nickel
DE69811506D1 (de) Hydrocyanierungsverfahren und darin verwendbare mehrzähnige phosphit liganden und katalysatorzusammensetzungen aus nickel
DE69900479D1 (de) Produkt aus SiC und Verfahren zu seiner Herstellung
EP1283707A4 (de) Polymerisierbare zusammensetzungen und verfahren zur deren verwendung
ATE389417T1 (de) Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
ATE399179T1 (de) Zusammensetzungen und verfahren für wt1- spezifische immunotherapie
ATE271598T1 (de) Desinfektionszusammensetzungen und verfahren
EP1185171A4 (de) Morphingluconat enthaltende zusammensetzungen und verfahren
DE69517683D1 (de) Alpha-galactosyl-epitope enthaltende zusammensetzungen und verfahren für impfstoffe
DE69822873D1 (de) Zusammensetzungen und verfahren zur gewichtsverringerung
DE60121896D1 (de) Verfahren und System zum Mischen von Silikonzusammensetzungen
DE60128788D1 (de) Zusammensetzung und verfahren zur bekämpfung von pflanzenschädlichen arthropoden
DE60041393D1 (de) Cytokine aus säugetieren, verwandte reagenzien und verfahren